ICU-acquired pneumonia in immunosuppressed patients with acute hypoxemic respiratory failure: A post-hoc analysis of a prospective international cohort study
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články
PubMed
33012580
DOI
10.1016/j.jcrc.2020.09.027
PII: S0883-9441(20)30706-1
Knihovny.cz E-zdroje
- Klíčová slova
- Immunosuppression, Infection, Pneumonia, Sepsis, VA-LRTI,
- MeSH
- jednotky intenzivní péče MeSH
- kohortové studie MeSH
- lidé MeSH
- mortalita v nemocnicích MeSH
- pneumonie * epidemiologie MeSH
- prospektivní studie MeSH
- respirační insuficience * epidemiologie MeSH
- rizikové faktory MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
OBJECTIVE: Intensive Care Units (ICU) acquired Pneumonia (ICU-AP) is one of the most frequent nosocomial infections in critically ill patients. Our aim was to determine the effects of having an ICU-AP in immunosuppressed patients with acute hypoxemic respiratory failure. DESIGN: Post-hoc analysis of a multinational, prospective cohort study in 16 countries. SETTINGS: ICU. PATIENTS: Immunosuppressed patients with acute hypoxemic respiratory failure. INTERVENTION: None. MEASUREMENTS AND MAIN RESULTS: The original cohort had 1611 and in this post-hoc analysis a total of 1512 patients with available data on hospital mortality and occurrence of ICU-AP were included. ICU-AP occurred in 158 patients (10.4%). Hospital mortality was higher in patients with ICU-AP (14.8% vs. 7.1% p < 0.001). After adjustment for confounders and centre effect, use of vasopressors (Odds Ratio (OR) 2.22; 95%CI 1.46-3.39) and invasive mechanical ventilation at day 1 (OR 2.12 vs. high flow oxygen; 95%CI 1.07-4.20) were associated with increased risk of ICU-AP while female gender (OR 0.63; 95%CI 0.43-94) and chronic kidney disease (OR 0.43; 95%CI 0.22-0.88) were associated with decreased risk of ICU-AP. After adjustment for confounders and centre effect, ICU-AP was independently associated with mortality (Hazard Ratio 1.48; 95%CI 14.-1.91; P = 0.003). CONCLUSIONS: The attributable mortality of ICU-AP has been repetitively questioned in immunosuppressed patients with acute respiratory failure. This manuscript found that ICU-AP represents an independent risk factor for hospital mortality.
Critical Care Center CHU Lille School of Medicine University of Lille Lille France
Department of Critical Care King's College Hospital NHS Foundation Trust London SE5 9RS UK
Department of Emergencies and Critical Care Oslo University Hospital Oslo Norway
Department of Intensive Care Hôpital Erasme Université Libre de Bruxelles Brussels Belgium
Department of Intensive Care Medicine Radboud University Medical Center Nijmegen The Netherlands
Department of Medical Intensive Care Medicine University Hospital of Angers Angers France
Department of Medicine 1 Medical University of Vienna Vienna Austria
Division of Pulmonary and Critical Care Penn State University College of Medicine Hershey PA USA
Medical Intensive Care Unit Hôtel Dieu HME University Hospital of Nantes Nantes France
Pulmonary and Critical Care Medicine Mayo Clinic Rochester MN USA
Citace poskytuje Crossref.org